Sex differences in the association of framingham cardiac risk score with cognitive decline in community-dwelling elders without clinical heart disease

Psychosomatic Medicine

Volumn 73, Issue 8, 2011, Pages 683-689

  Laughlin, Gail A ^a   McEvoy, Linda K ^a   Von Mühlen, Denise ^a   Lori B Daniels, ^b   Kritz Silverstein, Donna ^a   Bergstrom, Jaclyn ^a   Cummins, Kevin ^a   Der Martirosian, Claudia ^a   Jassal, Simerjot K ^c,d   Barrett Connor, Elizabeth ^a  

^a Department of Family and Preventive Medicine ^*  (United States)

^b Division of Cardiology   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

cardiovascular; cognitive function; ging; prospective

Indexed keywords

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; EDUCATIONAL STATUS; FEMALE; FRAMINGHAM RISK SCORE; FUNCTIONAL ASSESSMENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RECALL; SEX DIFFERENCE;

EID: 80053913302     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e31822f9089     Document Type: Article

References (41)

1. Stampfer MJ. Cardiovascular disease and Alzheimer's disease: common links. J Intern Med 2006;260:211-23. (Pubitemid 44253634)
2. Singh-Manoux A, Britton AR, Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II Study. J Am Geriatr Soc 2003; 51:1445-50. (Pubitemid 37259875)
3. Rafnsson SB, Deary IJ, Smith FB, Whiteman MC, Fowkes FG. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study. Psychosom Med 2007;69: 425-34. (Pubitemid 46987885)
4. Rafnsson SB, Deary IJ, Fowkes FG. Peripheral arterial disease and cognitive function. Vasc Med 2009;14:51-61.
5. Wendell CR, Zonderman AB, Metter EJ, Najjar SS, Waldstein SR. Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease. Stroke 2009;40:3180-5.
6. Cohen RA, Poppas A, Forman DE, Hoth KF, Haley AP, Gunstad J, Jefferson AL, Tate DF, Paul RH, Sweet LH, Ono M, Jerskey BA, Gerhard-Herman M. Vascular and cognitive functions associated with cardiovascular disease in the elderly. J Clin Exp Neuropsychol 2009;31:96-110.
7. Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev 2010;68(Suppl 2):S74-87.
8. Veglio F, Paglieri C, Rabbia F, Bisbocci D, Bergui M, Cerrato P. Hypertension and cerebrovascular damage. Atherosclerosis 2009;205:331-41.
9. Whitmer RA. Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 2007;7:373-80. (Pubitemid 47422778)
10. Birns J, Kalra L. Cognitive function and hypertension. J Hum Hypertens 2009;23:86-96.
11. Knopman DS. Cerebrovascular disease and dementia. Br J Radiol 2007; 80:S121-7. (Pubitemid 351799339)
12. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. (Pubitemid 28213628)
13. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 2006;92:1752-9. (Pubitemid 44851316)
14. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psy-chiatr Res 1975;12:189-98.
15. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.
16. Reitan R. Validity of the Trail-Making Test as an indicator of organic brain disease. Percept Mot Skills 1958;8:271-6.
17. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5:23-32.
18. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-25.
19. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 2001;153:132-6. (Pubitemid 32060603)
20. The Hypertension Detection and Follow-up Program: Hypertension Detection and Follow-up Program Cooperative Group. Prev Med 1976; 5:207-15.
21. Friedewald W, Levy R, Frederickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972;18:459-502.
22. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6. (Pubitemid 20255621)
23. Karlamangla AS, Singer BH, Reuben DB, Seeman TE. Increases in serum nonYhigh-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur Studies of Successful Aging. J Am Geriatr Soc 2004;52:487-94. (Pubitemid 38480624)
24. Reitz C, Luchsinger J, Tang MX, Manly J, Mayeux R. Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology 2005;64:1378-83. (Pubitemid 40570505)
25. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetesVsystematic overview of prospective observational studies. Diabetologia 2005;48:2460-9. (Pubitemid 41738208)
26. Johnston SC, O'Meara ES, Manolio TA, Lefkowitz D, O'Leary DH, Goldstein S, Carlson MC, Fried LP, Longstreth WT Jr. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 2004; 140:237-47.
27. de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-51. (Pubitemid 30078560)
28. Bots ML, van Swieten JC, Breteler MM, de Jong PT, van Gijn J, Hofman A, Grobbee DE. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993;341:1232-7. (Pubitemid 23146928)
29. de Leeuw FE, de Groot JC, Bots ML, Witteman JC, Oudkerk M, Hofman A, van Gijn J, Breteler MM. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 2000;247:291-6. (Pubitemid 30223967)
30. Barnes AJ, Locke P, Scudder PR, Dormandy TL, Dormandy JA, Slack J. Is hyperviscosity a treatable component of diabetic microcirculatory disease? Lancet 1977;2:789-91. (Pubitemid 8193247)
31. Kee DB Jr, Wood JH. Rheology of the cerebral circulation. Neurosurgery 1984;15:125-31. (Pubitemid 14055074)
32. Savaskan E, Hock C, Olivieri G, Bruttel S, Rosenberg C, Hulette C, Muller-Spahn F. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 2001;22:541-6. (Pubitemid 32607737)
33. Elias PK, Elias MF, D'Agostino RB, Sullivan LM, Wolf PA. Serum cholesterol and cognitive performance in the Framingham Heart Study. Psy-chosom Med 2005;67:24-30.
34. Ruitenberg A, Skoog I, Ott A, Aevarsson O, Witteman JC, Lernfelt B, van Harskamp F, Hofman A, Breteler MM. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001;12:33-9. (Pubitemid 32008939)
35. Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension 2005;45:374-9. (Pubitemid 40315806)
36. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 2009;54:1561-75.
37. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9. (Pubitemid 27118393)
38. Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol Aging 2009;30:946-56.
39. Kurland BF, Johnson LL, Egleston BL, Diehr PH. Longitudinal data with follow-up truncated by death: match the analysis method to research aims. Stat Sci 2009;24:211.
40. Wang L, van Belle G, Kukull WB, Larson EB. Predictors of functional change: a longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc 2002;50:1525-34. (Pubitemid 35024645)
41. DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol 2003;2:15-21.